Mizuho cuts Axsome Therapeutics target price to $272 from $284
AXSM•Mizuho cut its target price for Axsome Therapeutics to $272 from $284.
Related News
Adtran Holdings cut to neutral from buy by Rosenblatt; target price cut to $6.25 from $15
ADTN•
MoonLake Q3 R&D expenses rise 37% quarter over quarter to $68.9 million
MLTX•
Tesla's new registrations in Germany nearly quadruple in October, KBA says
TSLA•
Enanta Pharmaceuticals participates in Jefferies and Evercore healthcare conferences
ENTA•
Odyssey Therapeutics Q3 2026 net loss widens 50% to $53.1 million
ODTX•